These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10903792)

  • 41. 14th EORTC-NCI-AACR symposium on "Molecular Targets and Cancer Therapeutics," November 19-22, 2002, Frankfurt, Germany.
    Evans AE
    Med Pediatr Oncol; 2003 Dec; 41(6):541-4. PubMed ID: 14595711
    [No Abstract]   [Full Text] [Related]  

  • 42. 2020 ASCO Virtual Annual Meeting.
    Collingridge D
    Lancet Oncol; 2020 Jul; 21(7):885-886. PubMed ID: 32511985
    [No Abstract]   [Full Text] [Related]  

  • 43. What's new in surgical oncology.
    Norton JA
    J Am Coll Surg; 1996 Feb; 182(2):122-9. PubMed ID: 8564043
    [No Abstract]   [Full Text] [Related]  

  • 44. American Society of Clinical Oncology Annual Meeting 2019.
    Del Pozo Martín Y
    Lancet Haematol; 2019 Jul; 6(7):e349. PubMed ID: 31182415
    [No Abstract]   [Full Text] [Related]  

  • 45. Recent advances in medical oncology--1995-1996.
    Sikov WM
    Med Health R I; 1996 Mar; 79(3):92-9. PubMed ID: 8901289
    [No Abstract]   [Full Text] [Related]  

  • 46. My first American Society of Clinical Oncology annual meeting: inspiration, education, and perspective.
    Francis LK
    J Clin Oncol; 2005 Oct; 23(28):7245-6. PubMed ID: 16192621
    [No Abstract]   [Full Text] [Related]  

  • 47. The chemoprevention of cancer: directions for the future.
    Daly MB
    Cancer Epidemiol Biomarkers Prev; 1993; 2(6):509-12. PubMed ID: 8268765
    [No Abstract]   [Full Text] [Related]  

  • 48. [Present and future of therapeutic oncology].
    García G; Beltrán-Ortega A; Díaz-Perches R; de la Garza-Salazar JG; Noriega-Limón J; Jiménez-Zamudio L
    Gac Med Mex; 1984; 120(7-8):281-300. PubMed ID: 6526215
    [No Abstract]   [Full Text] [Related]  

  • 49. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
    Morgensztern D; Pennell NA; Subramanian J; Govindan R
    Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic targeting of tumor suppressor genes.
    Morris LG; Chan TA
    Cancer; 2015 May; 121(9):1357-68. PubMed ID: 25557041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncology.
    Yoshida T; Terada M
    JAMA; 1997 Jun; 277(23):1880-1. PubMed ID: 9185814
    [No Abstract]   [Full Text] [Related]  

  • 52. Highlights from 40th Annual Meeting of the American Society of Clinical Oncology New Orleans, LA, June 2004.
    Lee D
    Clin Colorectal Cancer; 2004 Sep; 4(3):154-8. PubMed ID: 15377398
    [No Abstract]   [Full Text] [Related]  

  • 53. [What is happening within cancer drug therapy? The Danish Society of Medical Oncology].
    Dansk Selskab for Medicinsk Onkologi's bestyrelse (DMO)
    Ugeskr Laeger; 2001 Mar; 163(12):1708. PubMed ID: 11284408
    [No Abstract]   [Full Text] [Related]  

  • 54. The future of clinical research in breast cancer: opportunities.
    Sledge GW
    Clin Breast Cancer; 2000 Jul; 1(2):95. PubMed ID: 11899657
    [No Abstract]   [Full Text] [Related]  

  • 55. Using oncology real-world evidence for quality improvement and discovery: the case for ASCO's CancerLinQ.
    Miller RS; Wong JL
    Future Oncol; 2018 Jan; 14(1):5-8. PubMed ID: 29052448
    [No Abstract]   [Full Text] [Related]  

  • 56. Recent progress in the treatment of cancer in children.
    Butler E; Ludwig K; Pacenta HL; Klesse LJ; Watt TC; Laetsch TW
    CA Cancer J Clin; 2021 Jul; 71(4):315-332. PubMed ID: 33793968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Updates in cancer research: insights from the AACR 100th Annual Meeting.
    Cho WC
    Expert Rev Mol Diagn; 2009 Jul; 9(5):411-6. PubMed ID: 19580426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. American Association for Cancer Research--100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. 18-22 April 2009, Denver, CO, USA.
    Mitra AP
    IDrugs; 2009 Jun; 12(6):339-41. PubMed ID: 19517310
    [No Abstract]   [Full Text] [Related]  

  • 59. [Promising targeted molecular therapies for the future years in non-small-cell lung cancer].
    Soria JC
    Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S35-6. PubMed ID: 16719155
    [No Abstract]   [Full Text] [Related]  

  • 60. American Society of Preventive Oncology 17th annual meeting.
    Fontham ET; Correa P
    Cancer Epidemiol Biomarkers Prev; 1993; 2(5):499-504. PubMed ID: 8220097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.